GSK

#121
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
57.8950 USD
-2.16%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
57.8250
57.9750
Годовой диапазон
42.8850
61.6950
Дневное изменение
-2.16%
Месячное изменение
+6.74%
6-месячное изменение
+32.03%
Годовое изменение
+32.03%
Предыдущее закрытие
59.1750
Открыть
57.8900
Bid
Ask
Минимум
57.8250
High
57.9750
Объем
963
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
Отчет о доходах Баланс Денежный поток
Значение Q4, 24Q4, 25 TTM

GSK plc American Depositary Shares (Each representing two Ordin

GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost.

Новости